4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000081
Chief Technology Officer sold 3,487 shares at an average $39.55 ($137,925)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stout Jay S Chief Technology Officer | 2026-07-08 | Sale | −1,906 | $39.53 | $75,344 | 209,779 | D |
| Stout Jay S Chief Technology Officer | 2026-07-08 | Sale | −105 | $39.99 | $4,199 | 209,674 | D |
| Stout Jay S Chief Technology Officer | 2026-07-08 | Sale | −1,399 | $39.53 | $55,302 | 208,275 | D |
| Stout Jay S Chief Technology Officer | 2026-07-08 | Sale | −77 | $39.99 | $3,079 | 208,198 | D |
| Open-market sales · 3,487 sh · avg $39.55 · $137,925 | |||||||
Loading xslF345X06/wk-form4_1783714376.xml…